312 Mrv0541 02231214352 d 16 16 0 0 1 0 999 V2000型4.5080 -0.1915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -0.1915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -2.6665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.4290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.4290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.1915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4916 0.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6665 0.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3166 0.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4916 1.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8415 0.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 2.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 10 2 0 0 0 0 2 11 2 0 0 0 0 3 15 2 10 0 0 0 0 4 1 0 0 0 0 4 15 1 0 0 0 0 5 11 1 0 0 0 0 5 15 1 0 0 0 0 6 7 1 0 0 0 0 6 9 6 10 1 1 0 0 0 0 0 0 0 0 6 11 1 0 0 0 0 7 8 1 0 0 0 0 7 12 1 0 0 0 0 8 13 1 0 0 0 0 9 14 1 0 0 0 0 13 16 1 0 0 0 0 M >结束
DB00312 >
drugbank >
预备(C) C1 (CC) C = O)数控(= O) NC1 = O >
InChI = 1 s / C11H18N2O3 c1-4-6-7(3) 11(5 -) 8(14)成员(16)13-9 (11)15 / h7H 4-6H2, 1-3H3, (H2, 12日,13日,14日,15日,16)>
WEXRUCMBJFQVBZ-UHFFFAOYSA-N >
C11H18N2O3 >
226.2722 >
226.131742452 >
3 >
34 >
-0.2480307952655508 >
23.407281054349895 >
1 >
2 >
0 >
1 >
(5-ethyl-5) - pentan-2-yl 1 3-diazinane-2 4 6-trione >
2.16 >
1.8932512466666667 >
-2.42 >
0 >
0 >
1 >
0 >
11.151888243105622 >
7.482022727708522 >
75.27 >
58.00289999999999 >
4 >
1 >
8.64 e-01 g / l >
生物素>
0 >
DB00312 >
APRD01174 >
批准;临床实验;vet_approved >
戊巴比妥>
(5-Ethyl-5) - 1-methyl-butyl -pyrimidine-2 4 6-trione;(5-Ethyl-5) - 1-methylbutyl 2, 4, 6 (1 h、3 h, 5 h) -pyrimidinetrione;(5-ethyl-5) - 1-methylbutyl巴比妥酸;(5-ethyl-5) - sec-pentyl巴比妥酸;戊巴比妥;Pentobarbitone >
Cafergot Pb一口;Cafergot Pb选项卡;戊巴比妥钠钠;戊巴比妥钠100毫克钠帽;戊巴比妥钠钠Inj 50毫克/毫升;Nova直肠一口25毫克;Nova直肠一口50毫克;Novo-pentobarb 100毫克;戊巴比妥钠;戊巴比妥钠帽50毫克>
戊巴比妥钠>
戊巴比妥钠$ $ $ $